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Abstract
Background: Sarcoidosis in pediatric age is uncommon and challenging diagnosis, because manifestations can be
significantly variable and non-specific since it is a multisystem disease, and virtually any organ system may be involved.
Case presentation: In this report, we describe the case of a 12-year-old girl presenting with fatigue and weight loss,
with a painless hepato-splenomegaly without additional clinical signs on physical examination. In our patient, once we
had ruled out infections, malignancies and granulomatous diseases of childhood, we made diagnosis of sarcoidosis,
finding suggestive histological features in two different tissues (liver and lymph nodes) with lung involvement.
Conclusions: Our case points out that pediatricians should consider sarcoidosis in the differential diagnosis in case of
systemic symptoms, even in absence of other specific clinical clues, because they represent the most common clinical
manifestations on presentation in children, in order to refer promptly the young patient to specialist evaluation.
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Background
Sarcoidosis is a multi-organ granulomatous disease,
characterized by non-caseating granulomas.
Two distinct types of sarcoidosis have been de-
scribed in childhood: the genetic and the classic one
(also known as pediatric-onset adult type sarcoidosis).
The first one is a monogenic autoinflammatory dis-
ease caused by mutations in the CARD15/NOD2
gene, that includes Blau syndrome and early-onset
sarcoidosis, which are the familial and the sporadic
forms of the same disease spectrum. Genetic sarcoid-
osis, which usually develops during the first years of
life, is characterized by the clinical triad of recurrent
granulomatous uveitis, dermatitis, and symmetric
arthritis-tenosynovitis [1, 2].
Classic sarcoidosis is a multifactorial disease, which
typically appears in early adulthood [3]. The incidence
varies widely throughout the world, from 1 up to 40
cases per 100,000 [4]. With an estimated annual inci-
dence of 2–3 cases per million, sarcoidosis in pediatric
age is uncommon and involves mainly pre-adolescents
and adolescents [5]. The clinical expression of this dis-
ease is protean and depends on the location of the
granulomas. Pulmonary involvement is observed in most
cases [6], especially in patients with a late onset, and it is
frequently associated with extra-pulmonary and consti-
tutional symptoms, while isolated extra-pulmonary dis-
ease is very uncommon.
We describe the challenges in considering sarcoidosis
as a rare cause of systemic symptoms such as fatigue
and weight loss in a young girl, illustrating the import-
ance of considering this diagnosis even in pediatric pa-
tients and in absence of respiratory symptoms.
Case presentation
A 12-year-old girl presented to her general pediatrician
complaining of asthenia and weight loss in the previous
month. Her past medical and family history were unre-
markable. Physical examination revealed a painless
hepato-splenomegaly without additional clinical signs.
Abdominal ultrasound revealed an inhomogeneous
liver appearance, abdominal lymphadenopathy and a
hypo-echogenic solid neoformation in front of the ce-
liac artery (35 × 13 mm). The patient was admitted to
the Department of Pediatrics of the Meyer Children’s
Hospital for further diagnostic investigations.
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Physical examination revealed palpable spleen and liver,
a right inguinal lymph node of 1 cm and a lymph node in
supraclavicular location, without any further objective
anomaly. She had no fever. Initial laboratory tests found
microcytic iron deficiency anemia (Hb = 9.8 g/dl, MCV =
65.5 ft., Ferritin = 4 ng/ml), with normal erythrocyte sedi-
mentation rate (ESR) and C-reactive protein (CRP), nor-
mal total protein and protein electrophoresis, a slight
increase of lipase and colic acids with normal amylase.
Blood biochemistry for kidney and liver function and urin-
alysis were normal. Primary immunologic work-up includ-
ing lymphocyte subset and immunoglobulin levels were
normal. Tests for malignancies (tumor markers and per-
ipheral blood smear) and infectious investigations, includ-
ingMantoux Test and IGRA Assay resulted negative.
Chest X-ray was negative. Magnetic resonance imaging
(MRI) examination of the superior and inferior abdomen
with contrast medium confirmed increased liver dimen-
sions and its structural inhomogeneity with zones of signal
alteration: some nodular, other confluent. It also revealed
increased spleen size with zones of nodular signal alter-
ation and multiple nodular formations in the following lo-
cations: hepatic hilar, mesenteric, lombo-aortic, at the
retrocavity of the epiploon, and the greatest one in front
of the celiac artery (diameter > 3.5 cm).
Suspecting a systemic lymphoproliferative disease, we
performed liver and lymph node ultrasound-guided biopsy,
which showed negativity of Polymerase chain reaction
(PCR) for potential agents of infectious diseases (including
Mycobacteria and Bartonella species) on lymph node ma-
terial, while it highlighted a non-necrotizing granulomatous
inflammation, resembling sarcoidosis, and aspects of
non-specific inflammation of the liver. (Fig. 2a, 1a).
Subsequently, we carried out measurements of
serum and urinary calcium, serum phosphorus,
Angiotensin-Converting Enzyme (ACE), followed by a
complete cardiac evaluation, and a complete ophthal-
mologic evaluation (including slit lamp), all of which
resulted within normality.
At this point, given the biopsy results, we performed fur-
ther lung studies: pulmonary function tests which showed
mild restriction and decreased alveolar capillary diffusion.
The chest X-Ray revaluation revealed a pattern compatible
with mild fibrosis and enlarged lymph nodes. We decided
to carry out a high-resolution chest computed tomography
(CT), which showed widespread fibrous strands and mul-
tiple enlarged lymph nodes (right paratracheal area, at the
supraaortic trunk origin, subcarinal, with the largest in this
location measuring 30 × 17 mm, pericardiophrenic, bilat-
erally at axillary level and along the mammary vessels). The
bronchoscopic investigation with analysis of the
broncho-alveolar lavage (BAL) fluid revealed: macrophages
70%, neutrophils 4% and lymphocytes 26% with a CD4/
CD8 ratio of 9.2 (pathological value > 3.5).
Based on these results, we carried out further investi-
gations on liver tissue and lymph node with histochem-
ical techniques: CD68 + nodules were found, suggestive
of microgranulomas (Fig. 1b and 2b).
Having ruled out other diagnoses, with suggestive
histological findings in two different tissues (liver and
lymph nodes) and considering lung involvement, we
made the diagnosis of pediatric-onset adult sarcoidosis.
During hospitalization, the condition of the child had
always been good and she had always been afebrile. Con-
sidering lymph node hypertrophy and the signs of initial
portal hypertension (due to compression of the hepatic
vessels), we started therapy with prednisone 40 mg/day,
and subsequent cross-therapy with mycophenolate mo-
fetil (250 mg/m2 increasing up to 1 g/m2).
The girl came back to our attention a month after dis-
charge for a follow-up visit: she was found in good gen-
eral condition, with hepatomegaly and without other
clinical signs or symptoms. A brain MRI was performed
in order to rule out cerebral involvement and it revealed
normal findings. One year later she maintained good
clinical condition and normal laboratory tests, therefore
MMF was gradually reduced and definitively suspended
after 18 months. Now her periodic follow up consist of
Fig. 1 Liver biopsy revealed the presence of small non-caseating granulomas (a) consisting of inflammatory epitheliod cells showing positive
immunostaining for the monocyte/macrophages marker CD68 (b). Original Magnification: 10X
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clinical and laboratory evaluation every 6 months and
annual pulmonary function tests, unless clinical or la-
boratory new findings.
Discussion and conclusions
Classic sarcoidosis is a rare and poorly described entity in
childhood. Clinical manifestations can be significantly
variable and non-specific since it is a multisystem disease,
and virtually any organ system may be involved. Systemic
symptoms as fatigue, fever and weight loss, that in chil-
dren are usually attributed to infectious, metabolic or lym-
phoproliferative disorders, are the most common clinical
manifestations on presentation, contrary to adults [7].
Cough, dyspnea, crackles and rhonchi at auscultation
are the classic clinical features of lung involvement. Chest
X-rays result normal in 44% of cases, but high-resolution
CT (HRCT) scans reveal abnormalities, mainly nodules
with ground-glass opacities and hilo-mediastinal lymph-
adenopathies, in 95% of children [8]. Restrictive lung dis-
ease is the typical alteration found in static and dynamic
pulmonary function tests. An elevated CD4/CD8 ratio (≥
3.5) of the BAL can be a helpful tool in the diagnosis of
sarcoidosis, although highly specific but not sensitive [9].
Extra-pulmonary sarcoidosis, mainly associated with a
concomitant thoracic involvement, is common and often
clinically silent. Liver, spleen, peripheral lymph nodes,
skin, eyes, heart and central nervous system are the most
commonly involved sites [10].
There is no specific diagnostic test for sarcoidosis,
and diagnosis can be considered reliable in presence
of suggestive clinical and radiologic manifestations,
and histological evidence of non-necrotizing granu-
lomas, when every alternative disease can be reason-
ably excluded [11, 12].
Our patient presented a subtle disease onset, with gen-
eral symptoms as asthenia and weight loss. Clinical
examination subsequently revealed involvement of liver
and spleen, in absence of cutaneous or musculoskeletal
signs or sympthoms.
In presence of negative laboratory tests (inflammatory
markers, liver function tests, electrolytes, infectious in-
vestigations), and chest X-ray, abdominal MRI and bi-
opsy were first oriented to assess a lymphoproliferative
disease. Histology in lymph node and liver tissue allowed
us to exclude both lymphoma and infectious agents,
while it revealed non-caseating granulomas.
Granulomatous disorders comprise a large family sharing
the common histological denominator of granuloma forma-
tion, in which granuloma acts as a complex inflammatory
focus in which organisms or other substances resistant to
degradation are circumscribed. Infections are the prevalent
underlying aetiology of granulomas: tuberculosis, toxoplas-
mosis, leishmaniosis, syphilis, brucellosis, fungal (Blasto-
mycosis, cryptococcosis, histoplasmosis), and viral hepatitis
(Hepatitis C, CMV, EBV) are the most common causes
[13]. Among non-infectious diseases, we can consider neo-
plasm, adverse drug reactions, and systemic autoimmune
disorders; while chronic granulomatous disease of child-
hood, Kikuchi’s disease and Melkersson-Rosenthal Syn-
drome are unusual causes [13–15] (Table 1). In the
Western world, sarcoidosis and tuberculosis are the two
major causes of granulomas [16].
In our patient, once we had ruled out infections, ma-
lignancies and granulomatous diseases of childhood, we
considered the possibility of sarcoidosis with an appar-
ently exclusive extra-pulmonary expression. Although in
the absence of clinical signs and alterations at chest
X-ray, pulmonary function tests were considered, since
they are easy to perform and non-invasive. They con-
firmed a restrictive lung disease, promoting further
exams (HRCT and BAL), which provided additional data
in favor of sarcoidosis.
Long-term studies in children are lacking, but progno-
sis seems to be similar to adults, with most patients
showing spontaneous improvement [17]. However, sar-
coidosis remains an enigmatic disease with high variabil-
ity in extent, severity and long-term outcome. At
present there is no curative treatment regimen and,
Fig. 2 Lymphonode biopsy revealed the presence of small non-caseating granulomas (a) consisting of inflammatory epitheliod cells showing
positive immunostaining for the monocyte/macrophages marker CD68 (b). Original Magnification: 10X
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since a large percentage of cases have a self-limiting
course (with spontaneous remission in few years), treat-
ment should be administered with caution [15, 18, 19].
Corticosteroids are the first-line therapy; second-line
drugs include different alternatives such as methotrex-
ate, TNFα-antagonists, cyclophosphamide, mycopheno-
late mofetil (MMF) and tacrolimus. [20]
We decided to treat our patient because of an initial com-
pression of portal venules by lymph nodes and the enlarge-
ment of chest lymph nodes. Considering her remarkable
liver involvement, MMF was than introduced (together with
prednisolone) as an adjunctive steroid-sparing treatment
[21]. The addition of MMF to corticosteroids is a viable and
safe treatment option in sarcoidosis; it allows a significant
reduction of maintenance corticosteroids while preserving a
stable or even improved clinical condition [22, 23].
The aim of therapy, when pulmonary disease is progres-
sive, is to avoid fibrosis, honeycombing and irreversible
lung disease. Absolute indications include progressive stage
III disease with symptoms, progressive restriction and spe-
cific pulmonary function changes. Several conditions re-
quire treatment in order to prevent a poor outcome:
posterior or intermediate uveitis; anterior uveitis refractory
to topical therapy; disfiguring cutaneous disease (e.g., lupus
pernio); cardiac sarcoidosis (when it causes cardiomyop-
athy, dysrhythmias, or atrioventricular block); brain or
spinal cord sarcoidosis (except for isolated VII cranial nerve
palsy or mild acute aseptic meningitis); symptomatic
hepato-splenic sarcoidosis (i.e. pain, consumptive cytopenia,
nausea); and significant hypercalcemia [24, 25].
In conclusion pediatric sarcoidosis is a challenging
diagnosis [26], due to lack of specific signs and symp-
toms. For this reason, general pediatricians should con-
sider sarcoidosis in the differential diagnosis in case of
fatigue, fever and weight loss, that represent the most
common clinical manifestations on presentation in chil-
dren, in order to refer promptly the young patient to
specialist evaluation [27].
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